Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers

Core Insights - Smith+Nephew has announced an exclusive collaboration with Healthcare Outcomes Performance Company (HOPCo) to enhance digital health solutions for ambulatory surgical center (ASC) customers, physicians, and patients [1][8] - The partnership aims to integrate HOPCo's advanced analytics and digital platforms, myrecovery® and Vitals®, with Smith+Nephew's CORI Surgical System to improve surgical planning and patient outcomes [2][14] Company Overview - Smith+Nephew is a global medical technology company founded in 1856, operating in over 100 countries, and generating annual sales of $5.5 billion in 2023 [11][16] - The company focuses on the repair, regeneration, and replacement of soft and hard tissue, with a mission to restore patients' bodies and self-belief through innovative technology [16] Collaboration Details - The collaboration will leverage HOPCo's data-driven insights and analytics to enhance the capabilities of the CORI Surgical System, providing surgeons with improved analytics for personalized surgical planning and decision-making [2][14] - HOPCo's myrecovery platform will utilize patient engagement tools and provide critical quality outcome metrics, while the Vitals platform will offer analytics and dashboards to improve care coordination and efficiency [14][15] Strategic Importance - This partnership underscores Smith+Nephew's commitment to advancing orthopedic surgery through innovative technology, aiming to improve patient outcomes and transform healthcare delivery [8][15] - The integration of HOPCo's solutions is expected to unlock value in the ASC segment by utilizing remote therapeutic monitoring (RTM), patient-reported outcomes (PROMs), and analytics to drive efficiencies [8][14]